This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT a document type you can select as a starting document when starting a ... (Read 86 times)

rlane42

  • Hero Member
  • *****
  • Posts: 594
Which of the following is NOT a document type you can select as a starting document when starting a mail merge?
 
  A) Letters
  B) E-mail messages
  C) Bibliographies
  D) Directory

Question 2

A template is a pre-made SharePoint site that is completely finished and needs no more development.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Harbringer

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

C

Answer to Question 2

FALSE




rlane42

  • Member
  • Posts: 594
Reply 2 on: Aug 28, 2018
Gracias!


yeungji

  • Member
  • Posts: 319
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library